BLT 0.00% 2.6¢ benitec biopharma limited

Hep C - adherence issues, page-7

  1. 2,524 Posts.
    lightbulb Created with Sketch. 69
    Yeah, on the hep c forum I'm on, all the studies and trial patients have been saying that geno 3 is the new geno 1. It's now changed roles as the hardest to treat, whereas it was the "easiest" before. Thanks, Hoy. Great article.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.